Schreiber, R., Lewis, C., & Crane, K. (2018). Patient Assessment of Foam Attributes from the Tazarotene Foam, 0.1%, Phase III Trials and Potential Impact on Patient Compliance. SKIN The Journal of Cutaneous Medicine, 2, S57. https://doi.org/10.25251/skin.2.supp.57